Trevena

Developer of GPCR ligand technology based therapeutics for cardiovascular diseases and pain

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2007 groups35 employees language trevena.com

Registered entities

Innovation

20 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,466 times.

YearFilings
20143
20155
20166
20178
20188
20196
20206
20219
20228
20239
20248
20252

Investor mix

8 investors on record; lead investors include Polaris Partners, New Enterprise Associates, Alta Partners, Healthcare Ventures; 1 has since exited.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%
Coming soon